Leigh Ellis

18PUBLICATIONS
152CO-AUTHORS
Nanotoxicology, health and safetyMolecular targetsCancer geneticsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 14, 2026
EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.

|Aug 20, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

Beatriz German, Katherine L Morel, Teia Noel

|Aug 12, 2025
SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer.

John T Phoenix, Audris Budreika, Devin A Schmeck

|Aug 08, 2024
MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer.

Beatriz German, Sarah A Alaiwi, Kun-Lin Ho

|Jun 04, 2024
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer.

Nadia Boufaied, Paolo Chetta, Tarek Hallal

|Feb 14, 2024
MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer.

Beatriz German, Jagpreet N Singh, Marcos AdS Fonseca

Pageof 3

Frequent Collaborators

5 joint publications

Henry W Long

5 joint publications

Xintao Qui

5 joint publications

David P Labbé

5 joint publications

Katherine L Morel